Teresa Kemp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Teresa Kemp has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Belinda Cochrane
Department of Respiratory and Sleep Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia
3 shared publications - Jonathan Shung-Yi Lee
Department of Respiratory and Sleep Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia
3 shared publications - Luisa Garcia
School of Nursing and Midwifery, Western Sydney University
3 shared publications - Sheree Smith
Faculty of Health and Medical Science, University of Adelaide, Adelaide, SA, Australia
3 shared publications - Soo Foo
Department of Respiratory and Sleep Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia
3 shared publications - Tracy A Smith
Department of Respiratory and Sleep Medicine, Westmead Hospital, Westmead, NSW, Australia
3 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-15
Breathlessness Matters – Australian Cohort Study Evaluating the Impact of a Multidisciplinary, Home-Based Breathlessness Intervention Service Targeting Patients with Chronic Obstructive Pulmonary Disease (COPD)
Background and Objectives: Chronic breathlessness causes reduced quality of life (QoL) and high healthcare costs. Accumulating evidence shows that multidisciplinary breathlessness services can ameliorate breathlessness which persists despite guideline-directed treatments. Current literature largely reflects trials of interventions in European settings applied to cancer-predominant populations, raising doubt about broad applicability. The research objective was to evaluate whether Macarthur Breathless Clinic (MBC), a bespoke health service intervention, could reduce the impact of chronic breathlessness for a cohort of Australians with COPD. Methods: The MBC intervention was tested in a prospective, single-arm cohort study, targeting recruitment of 92 patients. Eligible patients had chronic breathlessness impacting QoL and at least moderately severe COPD, defined by spirometry. Following detailed case review to ensure optimal medical therapy, an individualized program was developed and implemented by MBC’s multidisciplinary team during a nine-week program. Questionnaires assessing breathlessness burden, mental health and QoL were administered at baseline, repeated on program completion and again at 12 months. Results: Eighty-nine eligible subjects were mean age 71 years, 65% female and 10% Aboriginal Australian with 18% reporting breathlessness at rest. Mean FEV1 was 37% predicted. Compared with baseline, the primary outcome, Chronic Respiratory Questionnaire – Mastery Subscale improved after program completion (0.5 at nine and 0.8 at 52 weeks, p< 0.0001). Measures of confidence, COPD symptom burden and breathlessness also yielded durable positive results at 12 months. Conclusion: Clinically relevant gains seen after MBC were retained or even increased at 12 months and more reflected enhanced coping skills and confidence than reduced breathlessness intensity. Plain Language Summary: Breathlessness is a distressing, disabling symptom, contributing to high healthcare costs. Hence, addressing breathlessness represents an unmet need for patients and a health system priority. Breathlessness intervention services, largely comprising non-pharmacological strategies have proven beneficial for patients in the short term; largely for those patients with life-limiting disease such as cancer. Chronic obstructive pulmonary disease (COPD) and emphysema are common conditions, increasing in prevalence worldwide. Even with best available treatments, such patients have persistent and pervasive symptom burden, particularly from breathlessness. This research explores the utility of a breathlessness intervention service for durable impact when applied to patients with COPD. We report sustained improvements in breathlessness mastery and related symptom burden at 12 months following a multidisciplinary, home-based breathlessness intervention program in a cohort of Australians with COPD.
- 1 June 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-15
Open AccessBreathlessness Matters – Australian Cohort Study Evaluating the Impact of a Multidisciplinary, Home-Based Breathlessness Intervention Service Targeting Patients with Chronic Obstructive Pulmonary Disease (COPD)
Background and Objectives: Chronic breathlessness causes reduced quality of life (QoL) and high healthcare costs. Accumulating evidence shows that multidisciplinary breathlessness services can ameliorate breathlessness which persists despite guideline-directed treatments. Current literature largely reflects trials of interventions in European settings applied to cancer-predominant populations, raising doubt about broad applicability. The research objective was to evaluate whether Macarthur Breathless Clinic (MBC), a bespoke health service intervention, could reduce the impact of chronic breathlessness for a cohort of Australians with COPD. Methods: The MBC intervention was tested in a prospective, single-arm cohort study, targeting recruitment of 92 patients. Eligible patients had chronic breathlessness impacting QoL and at least moderately severe COPD, defined by spirometry. Following detailed case review to ensure optimal medical therapy, an individualized program was developed and implemented by MBC’s multidisciplinary team during a nine-week program. Questionnaires assessing breathlessness burden, mental health and QoL were administered at baseline, repeated on program completion and again at 12 months. Results: Eighty-nine eligible subjects were mean age 71 years, 65% female and 10% Aboriginal Australian with 18% reporting breathlessness at rest. Mean FEV1 was 37% predicted. Compared with baseline, the primary outcome, Chronic Respiratory Questionnaire – Mastery Subscale improved after program completion (0.5 at nine and 0.8 at 52 weeks, p< 0.0001). Measures of confidence, COPD symptom burden and breathlessness also yielded durable positive results at 12 months. Conclusion: Clinically relevant gains seen after MBC were retained or even increased at 12 months and more reflected enhanced coping skills and confidence than reduced breathlessness intensity. Plain Language Summary: Breathlessness is a distressing, disabling symptom, contributing to high healthcare costs. Hence, addressing breathlessness represents an unmet need for patients and a health system priority. Breathlessness intervention services, largely comprising non-pharmacological strategies have proven beneficial for patients in the short term; largely for those patients with life-limiting disease such as cancer. Chronic obstructive pulmonary disease (COPD) and emphysema are common conditions, increasing in prevalence worldwide. Even with best available treatments, such patients have persistent and pervasive symptom burden, particularly from breathlessness. This research explores the utility of a breathlessness intervention service for durable impact when applied to patients with COPD. We report sustained improvements in breathlessness mastery and related symptom burden at 12 months following a multidisciplinary, home-based breathlessness intervention program in a cohort of Australians with COPD.
- Open Access
- 2 April 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e85766
A Personalized, Home-Based, Multidisciplinary Outpatient Clinic for Managing Breathlessness in Chronic Obstructive Pulmonary Disease: Protocol for a Single-Arm, Mixed-Methods Cohort Study
Background: Breathlessness is a distressing symptom for people with chronic obstructive pulmonary disease (COPD), impacting independence and community participation, resulting in reduced quality of life. With optimized treatment, nonpharmaceutical interventions deployed in a home-based breathlessness intervention service may reduce breathlessness to a manageable level. Objective: The aim of this study is to investigate whether patients with COPD experience reduced burden of chronic breathlessness and health care use following participation in the Macarthur Breathless Clinic (MBC), a multidisciplinary home-based health service intervention and to explore participant and carer experiences. Methods: The proposed research is a single-site, mixed methods, single-arm cohort study evaluating MBC. Eligible participants will have chronic breathlessness as defined by a modified Medical Research Council score of at least 2 and COPD confirmed by spirometry. Initially, participants will undergo a holistic medical assessment to understand factors contributing to breathlessness and to optimize therapy. The MBC intervention will be a 9-week, home-based, multidisciplinary program (with contributions from medical, nursing, physiotherapy, and occupational therapy clinicians). Central to this program will be coaching for breathlessness self-management using individualized, multicomponent strategies. Breathlessness impact will be assessed using questionnaire instruments measuring breathlessness mastery, symptom burden, quality of life, and psychological distress, with the Chronic Respiratory Questionnaire’s mastery subscale as primary outcome. Assessments will be undertaken at baseline, 9 weeks, and 52 weeks; 12-month exacerbation rates, health care use, and rescue medication use will be monitored and measured against participants’ historical data. Participant and carer experiences will be evaluated using qualitative methods to inform development of the service. Results: This project was funded in stages according to defined milestones, with the final milestone payment received in October 2025. Data collection commenced in March 2022. On submission of this manuscript, recruitment is complete with 92 participants having completed the protocol by March 2024. Data analysis is ongoing, and results are expected to be reported by early 2027. Conclusions: This research protocol is the first to investigate long-term outcomes following a health service intervention targeting chronic breathlessness for patients with COPD. Positive results may see breathlessness strategies from MBC or other similar health service interventions incorporated into existing models of chronic COPD care. Trial Registration: Australian and New Zealand Clinical Trial Registry ACTRN12620001330932; https://tinyurl.com/35fec8h4 International Registered Report Identifier (IRRID): DERR1-10.2196/85766
- 2 April 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e85766
Open AccessA Personalized, Home-Based, Multidisciplinary Outpatient Clinic for Managing Breathlessness in Chronic Obstructive Pulmonary Disease: Protocol for a Single-Arm, Mixed-Methods Cohort Study
Background: Breathlessness is a distressing symptom for people with chronic obstructive pulmonary disease (COPD), impacting independence and community participation, resulting in reduced quality of life. With optimized treatment, nonpharmaceutical interventions deployed in a home-based breathlessness intervention service may reduce breathlessness to a manageable level. Objective: The aim of this study is to investigate whether patients with COPD experience reduced burden of chronic breathlessness and health care use following participation in the Macarthur Breathless Clinic (MBC), a multidisciplinary home-based health service intervention and to explore participant and carer experiences. Methods: The proposed research is a single-site, mixed methods, single-arm cohort study evaluating MBC. Eligible participants will have chronic breathlessness as defined by a modified Medical Research Council score of at least 2 and COPD confirmed by spirometry. Initially, participants will undergo a holistic medical assessment to understand factors contributing to breathlessness and to optimize therapy. The MBC intervention will be a 9-week, home-based, multidisciplinary program (with contributions from medical, nursing, physiotherapy, and occupational therapy clinicians). Central to this program will be coaching for breathlessness self-management using individualized, multicomponent strategies. Breathlessness impact will be assessed using questionnaire instruments measuring breathlessness mastery, symptom burden, quality of life, and psychological distress, with the Chronic Respiratory Questionnaire’s mastery subscale as primary outcome. Assessments will be undertaken at baseline, 9 weeks, and 52 weeks; 12-month exacerbation rates, health care use, and rescue medication use will be monitored and measured against participants’ historical data. Participant and carer experiences will be evaluated using qualitative methods to inform development of the service. Results: This project was funded in stages according to defined milestones, with the final milestone payment received in October 2025. Data collection commenced in March 2022. On submission of this manuscript, recruitment is complete with 92 participants having completed the protocol by March 2024. Data analysis is ongoing, and results are expected to be reported by early 2027. Conclusions: This research protocol is the first to investigate long-term outcomes following a health service intervention targeting chronic breathlessness for patients with COPD. Positive results may see breathlessness strategies from MBC or other similar health service interventions incorporated into existing models of chronic COPD care. Trial Registration: Australian and New Zealand Clinical Trial Registry ACTRN12620001330932; https://tinyurl.com/35fec8h4 International Registered Report Identifier (IRRID): DERR1-10.2196/85766
- Open Access
- 19 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
A Personalized, Home-Based, Multidisciplinary Outpatient Clinic for Managing Breathlessness in Chronic Obstructive Pulmonary Disease: Protocol for a Single-Arm, Mixed-Methods Cohort Study (Preprint)
BACKGROUND Breathlessness is a distressing symptom for people with chronic obstructive pulmonary disease (COPD), impacting independence and community participation, resulting in reduced quality of life. With optimized treatment, nonpharmaceutical interventions deployed in a home-based breathlessness intervention service may reduce breathlessness to a manageable level. OBJECTIVE The aim of this study is to investigate whether patients with COPD experience reduced burden of chronic breathlessness and health care use following participation in the Macarthur Breathless Clinic (MBC), a multidisciplinary home-based health service intervention and to explore participant and carer experiences. METHODS The proposed research is a single-site, mixed methods, single-arm cohort study evaluating MBC. Eligible participants will have chronic breathlessness as defined by a modified Medical Research Council score of at least 2 and COPD confirmed by spirometry. Initially, participants will undergo a holistic medical assessment to understand factors contributing to breathlessness and to optimize therapy. The MBC intervention will be a 9-week, home-based, multidisciplinary program (with contributions from medical, nursing, physiotherapy, and occupational therapy clinicians). Central to this program will be coaching for breathlessness self-management using individualized, multicomponent strategies. Breathlessness impact will be assessed using questionnaire instruments measuring breathlessness mastery, symptom burden, quality of life, and psychological distress, with the Chronic Respiratory Questionnaire’s mastery subscale as primary outcome. Assessments will be undertaken at baseline, 9 weeks, and 52 weeks; 12-month exacerbation rates, health care use, and rescue medication use will be monitored and measured against participants’ historical data. Participant and carer experiences will be evaluated using qualitative methods to inform development of the service. RESULTS This project was funded in stages according to defined milestones, with the final milestone payment received in October 2025. Data collection commenced in March 2022. On submission of this manuscript, recruitment is complete with 92 participants having completed the protocol by March 2024. Data analysis is ongoing, and results are expected to be reported by early 2027. CONCLUSIONS This research protocol is the first to investigate long-term outcomes following a health service intervention targeting chronic breathlessness for patients with COPD. Positive results may see breathlessness strategies from MBC or other similar health service interventions incorporated into existing models of chronic COPD care. CLINICALTRIAL Australian and New Zealand Clinical Trial Registry ACTRN12620001330932; https://tinyurl.com/35fec8h4 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/85766
- 19 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Personalized, Home-Based, Multidisciplinary Outpatient Clinic for Managing Breathlessness in Chronic Obstructive Pulmonary Disease: Protocol for a Single-Arm, Mixed-Methods Cohort Study (Preprint)
BACKGROUND Breathlessness is a distressing symptom for people with chronic obstructive pulmonary disease (COPD), impacting independence and community participation, resulting in reduced quality of life. With optimized treatment, nonpharmaceutical interventions deployed in a home-based breathlessness intervention service may reduce breathlessness to a manageable level. OBJECTIVE The aim of this study is to investigate whether patients with COPD experience reduced burden of chronic breathlessness and health care use following participation in the Macarthur Breathless Clinic (MBC), a multidisciplinary home-based health service intervention and to explore participant and carer experiences. METHODS The proposed research is a single-site, mixed methods, single-arm cohort study evaluating MBC. Eligible participants will have chronic breathlessness as defined by a modified Medical Research Council score of at least 2 and COPD confirmed by spirometry. Initially, participants will undergo a holistic medical assessment to understand factors contributing to breathlessness and to optimize therapy. The MBC intervention will be a 9-week, home-based, multidisciplinary program (with contributions from medical, nursing, physiotherapy, and occupational therapy clinicians). Central to this program will be coaching for breathlessness self-management using individualized, multicomponent strategies. Breathlessness impact will be assessed using questionnaire instruments measuring breathlessness mastery, symptom burden, quality of life, and psychological distress, with the Chronic Respiratory Questionnaire’s mastery subscale as primary outcome. Assessments will be undertaken at baseline, 9 weeks, and 52 weeks; 12-month exacerbation rates, health care use, and rescue medication use will be monitored and measured against participants’ historical data. Participant and carer experiences will be evaluated using qualitative methods to inform development of the service. RESULTS This project was funded in stages according to defined milestones, with the final milestone payment received in October 2025. Data collection commenced in March 2022. On submission of this manuscript, recruitment is complete with 92 participants having completed the protocol by March 2024. Data analysis is ongoing, and results are expected to be reported by early 2027. CONCLUSIONS This research protocol is the first to investigate long-term outcomes following a health service intervention targeting chronic breathlessness for patients with COPD. Positive results may see breathlessness strategies from MBC or other similar health service interventions incorporated into existing models of chronic COPD care. CLINICALTRIAL Australian and New Zealand Clinical Trial Registry ACTRN12620001330932; https://tinyurl.com/35fec8h4 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/85766